In murine models the blockade of the S100a8/S100a9 complex with small molecules or antibodies improves pathological conditions, while decreased expression of this complex correlates with better prognosis, as sepsis surviving patients shown decreased S100A8/A9 levels compared with non-survivors59. The gene discussed is IGKV1D-22; the disease is Sepsis.